1. Home
  2. DRDB vs LRMR Comparison

DRDB vs LRMR Comparison

Compare DRDB & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DRDB

Roman DBDR Acquisition Corp. II Ordinary shares

HOLD

Current Price

$10.42

Market Cap

319.5M

Sector

N/A

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.82

Market Cap

332.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRDB
LRMR
Founded
2024
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.5M
332.1M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
DRDB
LRMR
Price
$10.42
$3.82
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.71
AVG Volume (30 Days)
57.5K
1.5M
Earning Date
01-01-0001
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$595.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.87
$1.61
52 Week High
$10.47
$6.91

Technical Indicators

Market Signals
Indicator
DRDB
LRMR
Relative Strength Index (RSI) 47.42 56.10
Support Level $10.43 $3.12
Resistance Level $10.47 $3.69
Average True Range (ATR) 0.01 0.26
MACD -0.01 0.06
Stochastic Oscillator 9.09 97.51

Price Performance

Historical Comparison
DRDB
LRMR

About DRDB Roman DBDR Acquisition Corp. II Ordinary shares

Roman DBDR Acquisition Corp II is a blank check company.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: